{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:07:22Z","timestamp":1792814842098,"version":"4.5.0"},"reference-count":74,"publisher":"Bentham Science Publishers Ltd.","issue":"37","funder":[{"name":"\u201cChongqing Graduate Research Innovation Project\u201d","award":["CYS23343"],"award-info":[{"award-number":["CYS23343"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>This study aims to investigate the effect of Gallic Acid (GA) on\nthe alleviation of chemotherapy-induced bone marrow suppression, with a comparison\nto Diyu sheng bai tablets (DYSB) and RhG-CSF.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A mouse model of bone marrow suppression was established in BALB\/c mice\nusing intraperitoneal injections of cyclophosphamide (CTX). All procedures were performed\nafter obtaining ethical clearance from the institutional animal ethics committee.\nMice were treated with low (100 mg\/kg\/d), medium (200 mg\/kg\/d), and high (400\nmg\/kg\/d) doses of Gallic Acid (GA) to mitigate CTX-induced bone marrow suppression.\nIn parallel, mice in the positive control group were also treated with DYSB and\nRhG-CSF at their respective standard doses (DYSB: 100 mg\/kg\/day, RhG-CSF: 125\nmg\/kg\/day). The efficacy of GA in alleviating chemotherapy-induced bone marrow suppression\nwas evaluated through blood cell counts, immune organ (thymus and spleen) indices,\nbone marrow nucleated cell (BMNC) counts, cell cycle analysis, apoptosis, histopathology\nof bone marrow and spleen, and analysis of splenic hematopoietic factors.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>CTX induced a decrease in peripheral blood cells and BMNC counts, reduced\nspleen and thymus indices, and diminished abnormal pathology of bone marrow and\nspleen, as well as decreasing disturbances in hematopoietic factors. GA was able to alleviate\nthese abnormalities in the bone marrow. It modulated cell proliferation and apoptosis,\nadjusted the proportion of cells in the G0\/G1 phase, and reduced apoptosis in femoral\nbone marrow.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Gallic Acid (GA) alleviates chemotherapy-induced bone marrow suppression\nby improving immune organ function, promoting bone marrow cell recovery, and\ninhibiting apoptosis. These findings support GA as a potential adjunct therapy for chemotherapy,\nwith promising clinical applications.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0109298673354122241220051407","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T01:15:24Z","timestamp":1737508524000},"page":"8400-8416","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Effect of Gallic Acid on the Alleviation of the Chemotherapyinduced Myelosuppression"],"prefix":"10.2174","volume":"32","author":[{"given":"Junyi","family":"Luo","sequence":"first","affiliation":[{"name":"Department of Urology, Children\u2019s Hospital of Chongqing Medical University, Chongqing, 400014, P.R.,\nChina"},{"name":"Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering,\nChongqing, 400014, P.R., China"},{"name":"China International Science and Technology Cooperation base of Child\nDevelopment and Critical Disorders, National Clinical Research Center for Child Health and Disorders,\nMinistry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of\nPediatrics, Children\u2019s Hospital of Chongqing Medical University, Chongqing, 400014, P.R., China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxia","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Children\u2019s Hospital of Chongqing Medical University, Chongqing, 400014, P.R.,\nChina"},{"name":"Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering,\nChongqing, 400014, P.R., China"},{"name":"China International Science and Technology Cooperation base of Child\nDevelopment and Critical Disorders, National Clinical Research Center for Child Health and Disorders,\nMinistry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of\nPediatrics, Children\u2019s Hospital of Chongqing Medical University, Chongqing, 400014, P.R., China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Urology, Children\u2019s Hospital of Chongqing Medical University, Chongqing, 400014, P.R.,\nChina"},{"name":"Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering,\nChongqing, 400014, P.R., China"},{"name":"China International Science and Technology Cooperation base of Child\nDevelopment and Critical Disorders, National Clinical Research Center for Child Health and Disorders,\nMinistry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of\nPediatrics, Children\u2019s Hospital of Chongqing Medical University, Chongqing, 400014, P.R., China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Children\u2019s Hospital of Chongqing Medical University, Chongqing, 400014, P.R.,\nChina"},{"name":"Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering,\nChongqing, 400014, P.R., China"},{"name":"China International Science and Technology Cooperation base of Child\nDevelopment and Critical Disorders, National Clinical Research Center for Child Health and Disorders,\nMinistry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of\nPediatrics, Children\u2019s Hospital of Chongqing Medical University, Chongqing, 400014, P.R., China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyue","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Urology, Children\u2019s Hospital of Chongqing Medical University, Chongqing, 400014, P.R.,\nChina"},{"name":"Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering,\nChongqing, 400014, P.R., China"},{"name":"China International Science and Technology Cooperation base of Child\nDevelopment and Critical Disorders, National Clinical Research Center for Child Health and Disorders,\nMinistry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of\nPediatrics, Children\u2019s Hospital of Chongqing Medical University, Chongqing, 400014, P.R., China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"He","sequence":"additional","affiliation":[{"name":"Department of Urology, Children\u2019s Hospital of Chongqing Medical University, Chongqing, 400014, P.R.,\nChina"},{"name":"Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering,\nChongqing, 400014, P.R., China"},{"name":"China International Science and Technology Cooperation base of Child\nDevelopment and Critical Disorders, National Clinical Research Center for Child Health and Disorders,\nMinistry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of\nPediatrics, Children\u2019s Hospital of Chongqing Medical University, Chongqing, 400014, P.R., China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2991\/jegh.k.191008.001","volume":"9","author":"Mattiuzzi C.","year":"2019","unstructured":"Mattiuzzi C.; Current cancer epidemiology. J Epidemiol Glob Health  2019,9(4),217-222","journal-title":"J Epidemiol Glob Health"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"Sung H.","year":"2021","unstructured":"Sung H.; Ferlay J.; Siegel R.L.; Laversanne M.; Soerjomataram I.; Jemal A.; Bray F.; Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin  2021,71(3),209-249","journal-title":"CA Cancer J Clin"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1016\/S1470-2045(15)00079-0","volume":"16","author":"Turner N.","year":"2015","unstructured":"Turner N.; Biganzoli L.; Leo D.A.; Continued value of adjuvant anthracyclines as treatment for early breast cancer. Lancet Oncol  2015,16(7),e362-e369","journal-title":"Lancet Oncol"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","volume":"6","author":"Emadi A.","year":"2009","unstructured":"Emadi A.; Cyclophosphamide and cancer: Golden anniversary. Nat Rev Clin Oncol  2009,6(11),638-647","journal-title":"Nat Rev Clin Oncol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1006\/gyno.2001.6180","volume":"81","author":"Wagenaar H.C.","year":"2001","unstructured":"Wagenaar H.C.; Colombo N.; Vergote I.; Boes H.G.; Zanetta G.; Pecorelli S.; Lacave A.J.; Hoesel v.Q.; Cervantes A.; Bolis G.; Namer M.; Lhomm\u00e9 C.; Guastalla J.P.; Nooij M.A.; Poveda A.; di Palumbo S.V.; Vermorken J.B.; Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: An EORTC gynaecological cancer cooperative group study. Gynecol Oncol  2001,81(3),348-354","journal-title":"Gynecol Oncol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(19)32222-6","volume":"394","author":"Ares P.L.","year":"2019","unstructured":"Ares P.L.; Dvorkin M.; Chen Y.; Reinmuth N.; Hotta K.; Trukhin D.; Statsenko G.; Hochmair M.J.; \u00d6zg\u00fcro\u011flu M.; Ji J.H.; Voitko O.; Poltoratskiy A.; Ponce S.; Verderame F.; Havel L.; Bondarenko I.; Kazarnowicz A.; Losonczy G.; Conev N.V.; Armstrong J.; Byrne N.; Shire N.; Jiang H.; Goldman J.W.; Batagelj E.; Casarini I.; Pastor A.V.; Sena S.N.; Zarba J.J.; Burghuber O.; Hartl S.; Hochmair M.J.; Lamprecht B.; Studnicka M.; Schlittler A.L.; de Oliveira A.M.F.; Calabrich A.; Girotto C.G.; Reis D.P.; Gorini F.N.C.; De Marchi R.M.P.; Baldotto S.R.C.; Sette C.; Zukin M.; Conev N.V.; Dudov A.; Ilieva R.; Koynov K.; Krasteva R.; Tonev I.; Valev S.; Venkova V.; Bi M.; Chen C.; Chen Y.; Chen Z.; Fang J.; Feng J.; Han Z.; Hu J.; Hu Y.; Li W.; Liang Z.; Lin Z.; Ma R.; Ma S.; Nan K.; Shu Y.; Wang K.; Wang M.; Wu G.; Yang N.; Yang Z.; Zhang H.; Zhang W.; Zhao J.; Zhao Y.; Zhou C.; Zhou J.; Zhou X.; Havel L.; Kolek V.; Koubkova L.; Roubec J.; Skrickova J.; Zemanova M.; Chouaid C.; Hilgers W.; Lena H.; Sibilot M.D.; Robinet G.; Souquet P-J.; Alt J.; Bischoff H.; Grohe C.; Laack E.; Lang S.; Panse J.; Reinmuth N.; Schulz C.; Bogos K.; Cs\u00e1nky E.; F\u00fcl\u00f6p A.; Horv\u00e1th Z.; K\u00f3sa J.; Lacz\u00f3 I.; Losonczy G.; Pajkos G.; P\u00e1pai Z.; Sz\u00e9kely P.Z.; S\u00e1rosi V.; Somfay A.; Ezer S.\u00c9.; Telekes A.; Bar J.; Gottfried M.; Heching N.I.; Kuch Z.A.; Bartolucci R.; Bettini A.C.; Delmonte A.; Garassino M.C.; Minelli M.; Roila F.; Verderame F.; Atagi S.; Azuma K.; Goto H.; Goto K.; Hara Y.; Hayashi H.; Hida T.; Hotta K.; Kanazawa K.; Kanda S.; Kim Y.H.; Kuyama S.; Maeda T.; Morise M.; Nakahara Y.; Nishio M.; Nogami N.; Okamoto I.; Saito H.; Shinoda M.; Umemura S.; Yoshida T.; Claessens N.; Cornelissen R.; Heniks L.; Hiltermann J.; Smit E.; van den Brekel S.A.; Kazarnowicz A.; Kowalski D.; Ma\u0144dziuk S.; Mr\u00f3z R.; Wojtukiewicz M.; Ciuleanu T.; Ganea D.; Ungureanu A.; Dvorkin M.; Luft A.; Moiseenko V.; Poltoratskiy A.; Sakaeva D.; Smolin A.; Statsenko G.; Vasilyev A.; Vladimirova L.; Anasina I.; Chovanec J.; Demo P.; Godal R.; Kasan P.; Stresko M.; Urda M.; Cho E.K.; Ji J.H.; Kim J-H.; Kim S-W.; Lee G-W.; Lee J-S.; Lee K.H.; Lee K.H.; Lee Y.G.; Molla A.I.M.; Gomez D.M.; Mingorance I.D.J.; Casado I.D.; Brea L.M.; Tarruella M.M.; Bueno M.T.; Mendivil N.A.; Rodr\u00edguez P.A.L.; Aix P.S.; Campelo R.G.M.; Chang G-C.; Chen Y-H.; Chiu C-H.; Hsia T-C.; Lee K-Y.; Li C-T.; Wang C-C.; Wei Y-F.; Wu S-Y.; Alacac\u0131o\u011flu A.; \u00c7i\u00e7in I.; Demirkazik A.; Erman M.; G\u00f6ksel T.; \u00d6zg\u00fcro\u011flu M.; Adamchuk H.; Bondarenko I.; Kolesnik O.; Kryzhanivska A.; Ostapenko Y.; Shevnia S.; Shparyk Y.; Trukhin D.; Ursol G.; Voitko N.; Voitko O.; Vynnychenko I.; Babu S.; Chen Y.; Chiang A.; Chua W.; Dakhil S.; Dowlati A.; Goldman J.W.; Haque B.; Jamil R.; Knoble J.; Lakhanpal S.; Mi K.; Nikolinakos P.; Powell S.; Ross H.; Schaefer E.; Schneider J.; Spahr J.; Spigel D.; Stilwill J.; Sumey C.; Williamson M.; Durvalumab plus platinum\u2013etoposide versus platinum\u2013etoposide in first-line treatment of extensive- stage small-cell lung cancer (CASPIAN): A randomised, controlled, open-label, phase 3 trial. Lancet  2019,394(10212),1929-1939","journal-title":"Lancet"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S1470-2045(20)30059-0","volume":"21","author":"Shimada K.","year":"2020","unstructured":"Shimada K.; Yamaguchi M.; Atsuta Y.; Matsue K.; Sato K.; Kusumoto S.; Nagai H.; Takizawa J.; Fukuhara N.; Nagafuji K.; Miyazaki K.; Ohtsuka E.; Okamoto M.; Sugita Y.; Uchida T.; Kayukawa S.; Wake A.; Ennishi D.; Kondo Y.; Izumi T.; Kin Y.; Tsukasaki K.; Hashimoto D.; Yuge M.; Yanagisawa A.; Kuwatsuka Y.; Shimada S.; Masaki Y.; Niitsu N.; Kiyoi H.; Suzuki R.; Tokunaga T.; Nakamura S.; Kinoshita T.; Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): A multicentre, single-arm, phase 2 trial. Lancet Oncol  2020,21(4),593-602","journal-title":"Lancet Oncol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.2147\/IJN.S24711","volume":"7","author":"Liangran G.","year":"2012","unstructured":"Liangran G.; Combination of trail and actinomycin D liposomes enhances antitumor effect in non-small cell lung cancer. Int J Nanomedicine  2012,7,1449-60","journal-title":"Int J Nanomedicine"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.hoc.2017.06.012","volume":"31","author":"Adair J.E.","year":"2017","unstructured":"Adair J.E.; Kubek S.P.; Kiem H.P.; Hematopoietic stem cell approaches to cancer. Hematol Oncol Clin North Am  2017,31(5),897-912","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1002\/ohn.222","volume":"168","author":"Hong D.Z.","year":"2023","unstructured":"Hong D.Z.; Ong T.C.C.; Timbadia D.P.; Tan H.T.A.; Kwa E.D.; Chong W.Q.; Goh B.C.; Loh W.S.; Loh K.S.; Tan E.C.; Tay J.K.; Systematic review and meta-analysis of the influence of genetic variation on ototoxicity in platinum-based chemotherapy. Otolaryngol Head Neck Surg  2023,168(6),1324-1337","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/00001622-200107000-00006","volume":"13","author":"Abid S.H.","year":"2001","unstructured":"Abid S.H.; Malhotra V.; Perry M.C.; Radiation-induced and chemotherapy-induced pulmonary injury. Curr Opin Oncol  2001,13(4),242-248","journal-title":"Curr Opin Oncol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.17219\/acem\/138318","volume":"30","author":"Kurt N.","year":"2021","unstructured":"Kurt N.; Gunes O.; Suleyman B.; Bakan N.; The effect of taxifolin on high-dose-cisplatin-induced oxidative liver injury in rats. Adv Clin Exp Med  2021,30(10),1025-1030","journal-title":"Adv Clin Exp Med"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s00120-021-01569-7","volume":"60","author":"Im Z.","year":"2021","unstructured":"Im Z.; Management of chemotherapy side effects and their long-term sequelae. Der Urologe Ausg A  2021,60(7),862-871","journal-title":"Der Urologe Ausg A"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"e24307","DOI":"10.1097\/MD.0000000000024307","volume":"100","author":"Yang S.","year":"2021","unstructured":"Yang S.; Traditional Chinese medicine on treating myelosuppression after chemotherapy: A protocol for systematic review and meta-analysis. Medicine  2021,100(4),e24307","journal-title":"Medicine"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1111\/j.1939-1676.2008.0179.x","volume":"22","author":"Elmslie R.E.","year":"2008","unstructured":"Elmslie R.E.; Glawe P.; Dow S.W.; Metronomic therapy with cyclophosphamide and piroxicam effectively delays tumor recurrence in dogs with incompletely resected soft tissue sarcomas. J Vet Intern Med  2008,22(6),1373-1379","journal-title":"J Vet Intern Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00280-016-3152-1","volume":"78","author":"Ahlmann M.","year":"2016","unstructured":"Ahlmann M.; Hempel G.; The effect of cyclophosphamide on the immune system: Implications for clinical cancer therapy. Cancer Chemother Pharmacol  2016,78(4),661-671","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.intimp.2011.04.011","volume":"11","author":"Huyan X.H.","year":"2011","unstructured":"Huyan X.H.; Lin Y.P.; Gao T.; Chen R.Y.; Fan Y.M.; Immunosuppressive effect of cyclophosphamide on white blood cells and lymphocyte subpopulations from peripheral blood of Balb\/c mice. Int Immunopharmacol  2011,11(9),1293-1297","journal-title":"Int Immunopharmacol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2174\/1381612805666230110215458","volume":"5","author":"Ludeman S.M.","year":"1999","unstructured":"Ludeman S.M.; The chemistry of the metabolites of cyclophosphamide. Curr Pharm Des  1999,5(8),627-643","journal-title":"Curr Pharm Des"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1007\/s12325-020-01419-6","volume":"37","author":"Epstein R.S.","year":"2020","unstructured":"Epstein R.S.; Aapro M.S.; Roy B.U.K.; Salimi T.; Krenitsky J.; Perkins L.M.L.; Girman C.; Schlusser C.; Crawford J.; Patient burden and real-world management of chemotherapy-induced myelosuppression: Results from an online survey of patients with solid tumors. Adv Ther  2020,37(8),3606-3618","journal-title":"Adv Ther"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s11655-020-3098-3","volume":"26","author":"Wang J.","year":"2020","unstructured":"Wang J.; Ying Y-Y.; Chen Z-H.; Shao K-D.; Zhang W-P.; Lin S-Y.; Guilu erxian glue () inhibits chemotherapy-induced bone marrow hematopoietic stem cell senescence in mice may via p16INK4a-rb signaling pathway. Chin J Integr Med  2020,26(11),819-824","journal-title":"Chin J Integr Med"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.15283\/ijsc.2014.7.1.12","volume":"7","author":"Ismail Z.M.K.","year":"2014","unstructured":"Ismail Z.M.K.; Amin N.M.A.; Yacoub M.F.Y.; Mohamed A.M.O.; Myelo- enhancement by Astragalus membranaceus in male albino rats with chemotherapy myelo-suppression. Histological and immunohistochemical study. Int J Stem Cells  2014,7(1),12-22","journal-title":"Int J Stem Cells"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.2217\/fon-2023-0513","volume":"20","author":"Crawford J.","year":"2024","unstructured":"Crawford J.; Herndon D.; Gmitter K.; Weiss J.; The impact of myelosuppression on quality of life of patients treated with chemotherapy. Future Oncol  2024,20(21),1515-1530","journal-title":"Future Oncol"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.2147\/IJN.S326629","volume":"16","author":"Song T.","year":"2021","unstructured":"Song T.; TPGS-Modified long-circulating liposomes loading ziyuglycoside I for enhanced therapy of myelosuppression. Int J Nanomedicine  2021,16,6281-6295","journal-title":"Int J Nanomedicine"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"110862","DOI":"10.1016\/j.biopha.2020.110862","volume":"132","author":"Haihong F.","year":"2020","unstructured":"Haihong F.; Ziyuglycoside II alleviates cyclophosphamide-induced leukopenia in mice via regulation of HSPC proliferation and differentiation. Biomed Pharmacother  2020,132,110862","journal-title":"Biomed Pharmacother"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"583334","DOI":"10.3389\/fphar.2020.583334","volume":"11","author":"Silin Z.","year":"2020","unstructured":"Silin Z.; Ginsenoside compound k regulates HIF-1\u03b1-Mediated glycolysis through Bclaf1 to inhibit the proliferation of human liver cancer cells. Front Pharmacol  2020,11,583334","journal-title":"Front Pharmacol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3390\/nu14081564","volume":"14","author":"Hongbo J.","year":"2022","unstructured":"Hongbo J.; Ginsenoside Rh4 suppresses metastasis of gastric cancer via SIX1-dependent TGF-\u03b2\/Smad2\/3 signaling pathway. Nutrients  2022,14(8),1564","journal-title":"Nutrients"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"112627","DOI":"10.1016\/j.ejmech.2020.112627","volume":"203","author":"Li X.","year":"2020","unstructured":"Li X.; Chu S.; Lin M.; Gao Y.; Liu Y.; Yang S.; Zhou X.; Zhang Y.; Hu Y.; Wang H.; Chen N.; Anticancer property of ginsenoside Rh2 from ginseng. Eur J Med Chem  2020,203,112627","journal-title":"Eur J Med Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.intimp.2019.04.003","volume":"72","author":"Liu X.","year":"2019","unstructured":"Liu X.; Zhang Z.; Liu J.; Wang Y.; Zhou Q.; Wang S.; Wang X.; Ginsenoside Rg3 improves cyclophosphamide-induced immunocompetence in Balb\/c mice. Int Immunopharmacol  2019,72,98-111","journal-title":"Int Immunopharmacol"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.3390\/ijms20122951","volume":"20","author":"Yao F.","year":"2019","unstructured":"Yao F.; Phenolic compounds and ginsenosides in ginseng shoots and their antioxidant and anti-inflammatory capacities in LPS-induced RAW264.7 mouse macrophages. Int J Mol Sci  2019,20(12),2951","journal-title":"Int J Mol Sci"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jgr.2018.07.009","volume":"43","author":"Han J.","year":"2019","unstructured":"Han J.; Xia J.; Zhang L.; Cai E.; Zhao Y.; Fei X.; Jia X.; Yang H.; Liu S.; Studies of the effects and mechanisms of ginsenoside Re and Rk on myelosuppression induced by cyclophosphamide. J Ginseng Res  2019,43(4),618-624","journal-title":"J Ginseng Res"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.3390\/ijms21072364","volume":"21","author":"Pricci M.","year":"2020","unstructured":"Pricci M.; Curcumin and colorectal cancer: From basic to clinical evidences. Int J Mol Sci  2020,21(7),2364","journal-title":"Int J Mol Sci"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.3390\/nu11122989","volume":"11","author":"Wnb W.M.T.","year":"2019","unstructured":"Wnb W.M.T.; Nh L.; Mechanistic understanding of curcumin\u2019s therapeutic effects in lung cancer. Nutrients  2019,11(12),2989","journal-title":"Nutrients"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/ptr.7757","volume":"37","author":"Al-Hawary S.S.I.","year":"2023","unstructured":"Al-Hawary S.S.I.; Jasim A.S.; Kadhim M.M.; Saadoon J.S.; Ahmad I.; Parra R.R.M.; Hammoodi H.S.; Abulkassim R.; Curcumin in the treatment of liver cancer: From mechanisms of action to nanoformulations. Phytother Res  2023,37(4),1624-1639","journal-title":"Phytother Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.msec.2015.05.077","volume":"55","author":"Hatamie S.","year":"2015","unstructured":"Hatamie S.; Akhavan O.; Sadrnezhaad S.K.; Ahadian M.M.; Shirolkar M.M.; Wang H.Q.; Curcumin-reduced graphene oxide sheets and their effects on human breast cancer cells. Mater Sci Eng C  2015,55,482-489","journal-title":"Mater Sci Eng C"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.2147\/DDDT.S327378","volume":"15","author":"Peng Y.","year":"2021","unstructured":"Peng Y.; Ao M.; Dong B.; Jiang Y.; Yu L.; Chen Z.; Hu C.; Xu R.; Anti-inflammatory effects of curcumin in the inflammatory diseases: Status, limitations and countermeasures. Drug Des Devel Ther  2021,15,4503-4525","journal-title":"Drug Des Devel Ther"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"156144","DOI":"10.1016\/j.cyto.2023.156144","volume":"164","author":"Mohammad J.D.","year":"2023","unstructured":"Mohammad J.D.; Antioxidant and anti-inflammatory effects of curcumin\/turmeric supplementation in adults: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials. Cytokine  2023,164,156144","journal-title":"Cytokine"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/01480545.2012.726626","volume":"36","author":"Ma P.","year":"2013","unstructured":"Ma P.; The influence of curcumin and (-)-epicatechin on the genotoxicity and myelosuppression induced by etoposide in bone marrow cells of male rats. Drug Chem Toxicol  2013,36(1),93-101","journal-title":"Drug Chem Toxicol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.cbi.2012.01.001","volume":"195","author":"Patra K.","year":"2012","unstructured":"Patra K.; Bose S.; Sarkar S.; Rakshit J.; Jana S.; Mukherjee A.; Roy A.; Mandal D.P.; Bhattacharjee S.; Amelioration of cyclophosphamide induced myelosuppression and oxidative stress by cinnamic acid. Chem Biol Interact  2012,195(3),231-239","journal-title":"Chem Biol Interact"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"114068","DOI":"10.1016\/j.foodres.2024.114068","volume":"180","author":"Zedong X.","year":"2024","unstructured":"Zedong X.; Dietary gallic acid as an antioxidant: A review of its food industry applications, health benefits, bioavailability, nano-delivery systems, and drug interactions. Food Res Int,  2024,180,114068","journal-title":"Food Res Int,"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.2147\/DDDT.S228123","volume":"14","author":"Dong W.","year":"2020","unstructured":"Dong W.; Gallic acid impedes non-small cell lung cancer progression via suppression of EGFR-dependent CARM1-PELP1 complex. Drug Des Devel Ther  2020,14,1583-1592","journal-title":"Drug Des Devel Ther"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.3390\/nu15163596","volume":"15","author":"Ran H.","year":"2023","unstructured":"Ran H.; Anticancer effect of gallic acid on acidity-induced invasion of MCF7 breast cancer cells. Nutrients  2023,15(16),3596","journal-title":"Nutrients"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"108444","DOI":"10.1016\/j.jnutbio.2020.108444","volume":"84","author":"Jang Y.G.","year":"2020","unstructured":"Jang Y.G.; Ko E.B.; Choi K.C.; Gallic acid, a phenolic acid, hinders the progression of prostate cancer by inhibition of histone deacetylase 1 and 2 expression. J Nutr Biochem  2020,84,108444","journal-title":"J Nutr Biochem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"110985","DOI":"10.1016\/j.biopha.2020.110985","volume":"133","author":"Jinrong B.","year":"2021","unstructured":"Jinrong B.; Gallic acid: Pharmacological activities and molecular mechanisms involved in inflammation-related diseases. Biomed Pharmacother  2021,133,110985","journal-title":"Biomed Pharmacother"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"e004037","DOI":"10.1136\/jitc-2021-004037","volume":"10","author":"Biaolong D.","year":"2022","unstructured":"Biaolong D.; Gallic acid induces T-helper-1-like Treg cells and strengthens immune checkpoint blockade efficacy. J Immunother Cancer  2022,10(7),e004037","journal-title":"J Immunother Cancer"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.1039\/C9FO00201D","volume":"10","author":"Guo M.Z.","year":"2019","unstructured":"Guo M.Z.; Meng M.; Feng C.C.; Wang X.; Wang C.L.; A novel polysaccharide obtained from Craterellus cornucopioides enhances immunomodulatory activity in immunosuppressive mice models via regulation of the TLR4-NF-\u03baB pathway. Food Funct  2019,10(8),4792-4801","journal-title":"Food Funct"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"115028","DOI":"10.1016\/j.jep.2022.115028","volume":"289","author":"Zeng M.","year":"2022","unstructured":"Zeng M.; Zhang Y.; Zhang X.; Zhang W.; Yu Q.; Zeng W.; Ma D.; Gan J.; Yang Z.; Jiang X.; Two birds with one stone: YQSSF regulates both proliferation and apoptosis of bone marrow cells to relieve chemotherapy-induced myelosuppression. J Ethnopharmacol  2022,289,115028","journal-title":"J Ethnopharmacol"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cncr.11882","volume":"100","author":"Crawford J.","year":"2004","unstructured":"Crawford J.; Chemotherapy-induced neutropenia: Risks, consequences, and new directions for its management. Cancer  2004,100(2),228-237","journal-title":"Cancer"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/1534735409360361","volume":"9","author":"Hosseinimehr S.J.","year":"2010","unstructured":"Hosseinimehr S.J.; Ahmadashrafi S.; Naghshvar F.; Ahmadi A.; Ehasnalavi S.; Tanha M.; Chemoprotective effects of Zataria multiflora against genotoxicity induced by cyclophosphamide in mice bone marrow cells. Integr Cancer Ther  2010,9(2),219-223","journal-title":"Integr Cancer Ther"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1248\/cpb.c19-00994","volume":"68","author":"Wang S.","year":"2020","unstructured":"Wang S.; Yang X.; Zhang Y.; Cai E.; Zheng X.; Zhao Y.; Li G.; Han M.; Yang L.; Study on the changes of chemical constituents in different compatibilities of ginseng- prepared rehmannia root and their effects on bone marrow inhibition after chemotherapy. Chem Pharm Bull  2020,68(5),428-435","journal-title":"Chem Pharm Bull"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.redox.2017.08.003","volume":"14","author":"Deng J.","year":"2018","unstructured":"Deng J.; Zhong Y.F.; Wu Y.P.; Luo Z.; Sun Y.M.; Wang G.E.; Kurihara H.; Li Y.F.; He R.R.; Carnosine attenuates cyclophosphamide-induced bone marrow suppression by reducing oxidative DNA damage. Redox Biol  2018,14,1-6","journal-title":"Redox Biol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2165\/00002018-200326100-00003","volume":"26","author":"Carey P.J.","year":"2003","unstructured":"Carey P.J.; Drug-induced myelosuppression. Drug Saf  2003,26(10),691-706","journal-title":"Drug Saf"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"103942","DOI":"10.1016\/j.jff.2020.103942","volume":"69","author":"Zhang W.N.","year":"2020","unstructured":"Zhang W.N.; Gong L.L.; Liu Y.; Zhou Z.B.; Wan C.X.; Xu J.J.; Wu Q-X.; Chen L.; Lu Y-M.; Chen Y.; Immunoenhancement effect of crude polysaccharides of Helvella leucopus on cyclophosphamide-induced immunosuppressive mice. J Funct Foods  2020,69,103942","journal-title":"J Funct Foods"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"e75097","DOI":"10.1371\/journal.pone.0075097","volume":"8","author":"Gridley D.S.","year":"2013","unstructured":"Gridley D.S.; Mao X.W.; Stodieck L.S.; Ferguson V.L.; Bateman T.A.; Moldovan M.; Cunningham C.E.; Jones T.A.; Slater J.M.; Pecaut M.J.; Changes in mouse thymus and spleen after return from the STS-135 mission in space. PLoS One  2013,8(9),e75097","journal-title":"PLoS One"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jgr.2019.01.001","volume":"44","author":"Han J.","year":"2020","unstructured":"Han J.; Dai M.; Zhao Y.; Cai E.; Zhang L.; Jia X.; Sun N.; Fei X.; Shu H.; Compatibility effects of ginseng and Ligustrum lucidum Ait herb pair on hematopoietic recovery in mice with cyclophosphamide-induced myelosuppression and its material basis. J Ginseng Res  2020,44(2),291-299","journal-title":"J Ginseng Res"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.gene.2013.06.058","volume":"528","author":"Dolgova E.V.","year":"2013","unstructured":"Dolgova E.V.; Efremov Y.R.; Orishchenko K.E.; Andrushkevich O.M.; Alyamkina E.A.; Proskurina A.S.; Bayborodin S.I.; Nikolin V.P.; Popova N.A.; Chernykh E.R.; Ostanin A.A.; Taranov O.S.; Omigov V.V.; Minkevich A.M.; Rogachev V.A.; Bogachev S.S.; Shurdov M.A.; Delivery and processing of exogenous double-stranded DNA in mouse CD34+ hematopoietic progenitor cells and their cell cycle changes upon combined treatment with cyclophosphamide and double-stranded DNA. Gene  2013,528(2),74-83","journal-title":"Gene"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s12013-014-0291-z","volume":"71","author":"Chen Q.","year":"2015","unstructured":"Chen Q.; Han X.; Wang W.; Zhao L.; Chen A.; Danggui sini decoction ameliorates myelosuppression in animal model by upregulating Thrombopoietin expression. Cell Biochem Biophys  2015,71(2),945-950","journal-title":"Cell Biochem Biophys"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0889-8588(05)70487-1","volume":"11","author":"Veiby O.P.","year":"1997","unstructured":"Veiby O.P.; Mikhail A.A.; Snodgrass H.R.; Growth factors and hematopoietic stem cells. Hematol Oncol Clin North Am  1997,11(6),1173-1184","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cell.2017.11.034","volume":"172","author":"Ioannis M.","year":"2018","unstructured":"Ioannis M.; Modulation of myelopoiesis progenitors is an integral component of trained immunity. Cell  2018,172(1-2),147-161.e12","journal-title":"Cell"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","volume":"39","author":"Garlanda C.","year":"2013","unstructured":"Garlanda C.; The interleukin-1 family: Back to the future. Immunity  2013,39(6),1003-1018","journal-title":"Immunity"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/stem.150327","volume":"15","author":"Eder M.","year":"1997","unstructured":"Eder M.; IL-3 in the clinic. Stem Cells  1997,15(5),327-333","journal-title":"Stem Cells"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ni.3153","volume":"16","author":"Hunter C.A.","year":"2015","unstructured":"Hunter C.A.; Jones S.A.; IL-6 as a keystone cytokine in health and disease. Nat Immunol  2015,16(5),448-457","journal-title":"Nat Immunol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.3390\/cells10082140","volume":"10","author":"Tsiftsoglou A.S.","year":"2021","unstructured":"Tsiftsoglou A.S.; Erythropoietin (EPO) as a key regulator of erythropoiesis, bone remodeling and endothelial transdifferentiation of multipotent mesenchymal stem cells (MSCs): Implications in regenerative medicine. Cells  2021,10(8),2140","journal-title":"Cells"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1055\/s-2006-939442","volume":"32","author":"Akkerman J.W.","year":"2006","unstructured":"Akkerman J.W.; Thrombopoietin and platelet function. Semin Thromb Hemost  2006,32(3),295-304","journal-title":"Semin Thromb Hemost"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"901277","DOI":"10.3389\/fimmu.2022.901277","volume":"13","author":"Kumar A.","year":"2022","unstructured":"Kumar A.; GM-CSF: A double-edged sword in cancer immunotherapy. Front Immunol  2022,13,901277","journal-title":"Front Immunol"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.stem.2019.02.014","volume":"24","author":"Waskow C.","year":"2019","unstructured":"Waskow C.; Spatiotemporal resolution of SCF supply in early hematopoiesis. Cell Stem Cell  2019,24(3),349-350","journal-title":"Cell Stem Cell"},{"key":"ref=66","first-page":"111","volume":"12","author":"Se J","year":"1994","unstructured":"Se J; Fw J; TNF-alpha, the great imitator: Role of p55 and p75 TNF receptors in hematopoiesis. Stem Cells  1994,12,111-26","journal-title":"Stem Cells"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1039\/C8TX00058A","volume":"7","author":"Shruthi S.","year":"2018","unstructured":"Shruthi S.; Shenoy B.K.; Genoprotective effects of gallic acid against cisplatin induced genotoxicity in bone marrow cells of mice. Toxicol Res  2018,7(5),951-958","journal-title":"Toxicol Res"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/tox.23018","volume":"36","author":"Shruthi S.","year":"2021","unstructured":"Shruthi S.; Shenoy K.B.; Gallic acid: A promising genoprotective and hepatoprotective bioactive compound against cyclophosphamide induced toxicity in mice. Environ Toxicol  2021,36(1),123-131","journal-title":"Environ Toxicol"},{"key":"ref=69","first-page":"204","volume":"15","author":"Baharmi S.","year":"2022","unstructured":"Baharmi S.; Kalantari H.; Kalantar M.; Goudarzi M.; Mansouri E.; Kalantar H.; Pretreatment with gallic acid mitigates cyclophosphamide induced inflammation and oxidative stress in mice. Curr Mol Pharmacol  2022,15(1),204-212","journal-title":"Curr Mol Pharmacol"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4172\/pharmaceutical-sciences.1000340","volume":"80","author":"Shruthi S","year":"2018","unstructured":"Shruthi S; Vijayalaxmi KK; Shenoy KB; Immunomodulatory effects of gallic acid against cyclophosphamide- and cisplatin-induced immunosuppression in swiss albino mice. Ind J Pharm Sci  2018,80(1),150-160","journal-title":"Ind J Pharm Sci"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"6056","DOI":"10.1080\/14786419.2022.2043307","volume":"36","author":"Zhang Y.","year":"2022","unstructured":"Zhang Y.; Liu J.; Wang Y.; Sun C.; Li W.; Qiu J.; Qiao Y.; Wu F.; Huo X.; An Y.; Zhang B.; Ma S.; Zheng J.; Ma X.; Nucleosides and amino acids, isolated from Cordyceps sinensis, protected against cyclophosphamide-induced myelosuppression in mice. Nat Prod Res  2022,36(23),6056-6059","journal-title":"Nat Prod Res"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.2174\/1386207326666230228120608","volume":"26","author":"Han J.","year":"2023","unstructured":"Han J.; Sun N.; Xing J.; Fei X.; Cai E.; Su F.; Effect and mechanism of specnuezhenide on chemotherapy-induced myelosuppression. Comb Chem High Throughput Screen  2023,26(13),2393-2400","journal-title":"Comb Chem High Throughput Screen"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12885-020-07742-z","volume":"21","author":"Liu Y.H.","year":"2021","unstructured":"Liu Y.H.; Qin H.Y.; Zhong Y.Y.; Li S.; Wang H.J.; Wang H.; Chen L.L.; Tang X.; Li Y.L.; Qian Z.Y.; Li H.Y.; Zhang L.; Chen T.; Neutral polysaccharide from Panax notoginseng enhanced cyclophosphamide antitumor efficacy in hepatoma H22-bearing mice. BMC Cancer  2021,21(1),37","journal-title":"BMC Cancer"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"e33733","DOI":"10.1371\/journal.pone.0033733","volume":"7","author":"Raghavendran H.R.B.","year":"2012","unstructured":"Raghavendran H.R.B.; Sathyanath R.; Shin J.; Kim H.K.; Han J.M.; Cho J.; Son C.G.; Panax ginseng modulates cytokines in bone marrow toxicity and myelopoiesis: Ginsenoside Rg1 partially supports myelopoiesis. PLoS One  2012,7(4),e33733","journal-title":"PLoS One"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673354122241220051407","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/238654\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673354122241220051407","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T04:20:47Z","timestamp":1760674847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/238654\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":74,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673354122241220051407","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-09-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}